Skip to main content
SpringerLink
Log in

Carvedilol: Solubilization and Cyclodextrin Complexation: A Technical Note

  • Brief/Technical Note
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. R. S. Carreira, P. Monteiro, L. M. Goncalves, and L. A. Providencia. Carvedilol: Just another beta-blocker or a powerful cardioprotector? Cardiovasc. Hematol. Disord. Drug Target. 6:257–266 (2006).

    CAS  Google Scholar 

  2. S. C. Sweetman (ed.), Martindale, the Complete Drug Reference, 33rd ed, The Pharmaceutical Press, London, 2002.

  3. X. Wen, F. Tan, Z. Jing, and Z. Liu. Preparation and study the 1:2 inclusion complex of carvedilol with b-cyclodextrin. J. Pharm. Biomed. Anal. 34:517–523 (2004).

    Article  PubMed  CAS  Google Scholar 

  4. B. Cappello, G. De Rosa, L. Giannini, et al. Cyclodextrin-containing poly(ethyleneoxide) tablets for the delivery of poorly soluble drugs: Potential as buccal delivery system. Int. J. Pharm. 319:63–70 (2006).

    Article  PubMed  CAS  Google Scholar 

  5. A. Miro, F. Quaglia, L. Giannini, B. Cappello, and M. I. La Rotonda. Drug/cyclodextrin solid systems in the design of hydrophilic matrixes: A strategy to modulate drug delivery rate. Curr. Drug Deliv. 3:373–378 (2006).

    Article  PubMed  CAS  Google Scholar 

  6. C. K. Oh; Assignee: SmithKline Beecham. Novel formulations of carvedilol. Patent No.: WO03028649, 10 April (2003).

  7. T. Loftsson, P. Jarho, M. Másson, and T. Järvinen. Cyclodextrins in drug delivery. Expert Opin. Drug Deliv. 2:335–351 (2005).

    Article  PubMed  CAS  Google Scholar 

  8. T. Loftsson, and D. Duchêne. Cyclodextrins and their pharmaceutical applications. Int. J. Pharm. 329:1–11 (2007).

    Article  PubMed  CAS  Google Scholar 

  9. P. Tomasik, and C. H. Schilling. Complexes of starch with inorganic guests. Advances in Carbohydrate Chemistry and Biochemistry, vol. 53, Academic, San Diego, 1998, pp. 263–343.

    Chapter  Google Scholar 

  10. P. Tomasik, and C. H. Schilling. Complexes of starch with organic guests. Advances in Carbohydrate Chemistry and Biochemistry, vol 53, Academic, San Diego, 1998, pp. 345–426.

    Chapter  Google Scholar 

  11. T. Loftsson, H. Fridriksdottir, and T. K. Gudmundsdottir. The effect of water-soluble polymers on aqueous solubility of drugs. Int. J. Pharm. 127:293–296 (1996).

    Article  CAS  Google Scholar 

  12. T. Loftsson, M. Másson, and M. E. Brewster. Self-association of cyclodextrins and cyclodextrin complexes. J. Pharm. Sci. 93:1091–1099 (2004).

    Article  PubMed  CAS  Google Scholar 

  13. M. Bonini, S. Rossi, G. Karlsson, M. Almgren, P. Lo Nostro, and P. Baglioni. Self-assembly of b-cyclodextrin in water. Part 1: Cryo-TEM and dynamic and static light scattering. Langmuir. 22:1478–1484 (2006).

    Article  PubMed  CAS  Google Scholar 

  14. Y. He, P. Fu, X. Shen, and H. Gao. Cyclodextrin-based aggregates and characterization by microscopy. Micron. 2008 (in press).

  15. T. Loftsson, K. Matthíasson, and M. Másson. The effects of organic salts on the cyclodextrin solubilization of drugs. Int. J. Pharm. 262:101–107 (2003).

    Article  PubMed  CAS  Google Scholar 

  16. T. Loftsson, M. Másson, and J. F. Sigurjónsdóttir. Methods to enhance the complexation efficiency of cyclodextrins. STP Pharma. Sci. 9:237–242 (1999).

    CAS  Google Scholar 

  17. T. Loftsson, D. Hreinsdóttir, and M. Másson. Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm. 302:18–28 (2005).

    Article  PubMed  CAS  Google Scholar 

  18. E. Redenti, L. Szente, and J. Szejtli. Cyclodextrin complexes of salts of acidic drugs. Thermodynamic properties, structural features, and pharmaceutical applications. J. Pharm. Sci. 90:979–986 (2001).

    Article  PubMed  CAS  Google Scholar 

  19. E. Redenti, L. Szente, and J. Szejtli. Drug/cyclodextrin/hydroxy acid multicomponent systems. Properties and pharmaceutical applications. J. Pharm. Sci. 89:1–8 (2000).

    Article  PubMed  CAS  Google Scholar 

  20. M. E. Brewster, and T. Loftsson. Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev. 59:645–666 (2007).

    Article  PubMed  CAS  Google Scholar 

  21. T. Loftsson, M. Másson, and H. H. Sigurdsson. Cyclodextrins and drug permeability through semi-permeable cellophane membranes. Int. J. Pharm. 232:35–43 (2002).

    Article  PubMed  CAS  Google Scholar 

  22. W. H. Streng, S. K. Hsi, P. E. Helms, and H. G. H. Tan. General treatment of pH-solubility profiles of weak acids and bases and the effects of different acids on the solubility of a weak base. J. Pharm. Sci. 73:1679–1684 (1984).

    Article  PubMed  CAS  Google Scholar 

  23. C. A. S. Bergström, K. Luthman, and P. Artursson. Accuracy of calculated pH-dependent aqueous drug solubility. Eur. J. Pharm. Sci. 22:387–398 (2004).

    Article  PubMed  Google Scholar 

  24. A. T. M. Serajuddin. Salt formation to improve drug solubility. Adv. Drug Deliv. Rev. 59:603–616 (2007).

    Article  PubMed  CAS  Google Scholar 

  25. T. Higuchi, and K. A. Connors. Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4:117–212 (1965).

    CAS  Google Scholar 

  26. T. Loftsson, and H. Friðriksdóttir. The effect of water-soluble polymers on the aqueous solubility and complexing abilities of b-cyclodextrin. Int. J. Pharm. 163:115–121 (1998).

    Article  CAS  Google Scholar 

  27. S. Schreier, S. V. P. Malheiros, and E. de Paula. Surface active drugs: Self-association and interaction with membranes and surfactants. Physicochemical and biological aspects. Biochim. Biophys. Acta–Mem. 1508:210–234 (2000).

    Article  CAS  Google Scholar 

  28. T. Loftsson, F. Konrádsdóttir, and M. Másson. Development and evaluation of an artificial membrane for determination of drug availability in pharmaceutical formulations. Int. J. Pharm. 326:60–68 (2006).

    Article  PubMed  CAS  Google Scholar 

  29. M. Franchini, G. M. Venkatesh; SmithKline Beecham Corporation: assignee. Carvedilol methanesulfonate. 6,515,010. Feb. 4.

  30. A. C. Moffat, M. D. Osselton, and B. Widdop (eds.), Clarke's Analysis of Drugs and Poisons, 3rd ed., Pharmaceutical Press, London, 2004, No. 2.

  31. W. Chen, K. A. Lamey, J. Malofiy, C. Oh; assignee: SmithKline Beecham Pharmaco Puerto Rico Inc. Carvedilol formulations. Patent No.: WO 03/092625 A2. 13 Nov. 2003.

  32. H. S. Yathirajan, S. Bindya, T. V. Sreevidya, B. Narayana, and M. Bolte. A second polymorph of carvedilol. Acta Cryst. E63:o542–o544 (2007).

    CAS  Google Scholar 

Download references

Acknowledgement

This investigation was funded by the University of Iceland Research Fund.

Author information

Authors and Affiliations

  1. Faculty of Pharmacy, University of Iceland, Hofsvallagata 53, IS-107, Reykjavik, Iceland

    Thorsteinn Loftsson, Stine Byskov Vogensen, Cyrielle Desbos & Phatsawee Jansook

Authors
  1. Thorsteinn Loftsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stine Byskov Vogensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cyrielle Desbos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Phatsawee Jansook
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thorsteinn Loftsson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Loftsson, T., Vogensen, S.B., Desbos, C. et al. Carvedilol: Solubilization and Cyclodextrin Complexation: A Technical Note. AAPS PharmSciTech 9, 425–430 (2008). https://doi.org/10.1208/s12249-008-9055-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-008-9055-7

Keywords

Search

Navigation